Enoxaparin Versus Unfractionated Heparin in Elective Percutaneous Coronary Intervention. 1-Year Results From the STEEPLE (SafeTy and Efficacy of Enoxaparin in Percutaneous coronary intervention patients, an internationaL randomized Evaluation) Trial

Gilles Montalescot, Richard Gallo, Harvey D. White, Marc Cohen, Ph Gabriel Steg, Philip E.G. Aylward, Christoph Bode, Massimo Chiariello, Spencer B. King, Robert A. Harrington, Walter J. Desmet, Carlos Macaya, Steven R. Steinhubl

Research output: Contribution to journalArticlepeer-review

37 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Enoxaparin Versus Unfractionated Heparin in Elective Percutaneous Coronary Intervention. 1-Year Results From the STEEPLE (SafeTy and Efficacy of Enoxaparin in Percutaneous coronary intervention patients, an internationaL randomized Evaluation) Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences